U.S. markets closed
  • S&P 500

    3,699.12
    +32.40 (+0.88%)
     
  • Dow 30

    30,218.26
    +248.74 (+0.83%)
     
  • Nasdaq

    12,464.23
    +87.05 (+0.70%)
     
  • Russell 2000

    1,892.45
    +43.75 (+2.37%)
     
  • Crude Oil

    46.09
    +0.45 (+0.99%)
     
  • Gold

    1,842.00
    +0.90 (+0.05%)
     
  • Silver

    24.32
    +0.18 (+0.76%)
     
  • EUR/USD

    1.2127
    -0.0022 (-0.18%)
     
  • 10-Yr Bond

    0.9690
    +0.0490 (+5.33%)
     
  • GBP/USD

    1.3438
    -0.0015 (-0.11%)
     
  • USD/JPY

    104.1400
    +0.2800 (+0.27%)
     
  • BTC-USD

    18,688.30
    +18,688.30 (+0.00%)
     
  • CMC Crypto 200

    365.19
    -14.05 (-3.71%)
     
  • FTSE 100

    6,550.23
    +59.96 (+0.92%)
     
  • Nikkei 225

    26,751.24
    -58.13 (-0.22%)
     

Cramer Weighs In On Lumentum, American Airlines And More

Craig Jones
·1 min read

On CNBC's "Mad Money Lightning Round," Jim Cramer said that Sarepta Therapeutics Inc (NASDAQ: SRPT) is good and he would own it, but he prefers Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX).

Cramer would be careful with Lumentum Holdings Inc (NASDAQ: LITE) because this group has always hurt him when it has gotten this hot.

Royalty Pharma plc (NASDAQ: RPRX) is a good opportunity, said Cramer. He is a buyer of the stock.

Cramer sees more upside potential for American Airlines Group Inc (NASDAQ: AAL). In the long term, he likes Southwest Airlines Co (NYSE: LUV) better.

TJX Companies Inc (NYSE: TJX) is a very large position for Cramer's charitable trust and he thinks that it is a buy.

Instead of Southern Co (NYSE: SO), Cramer would rather buy Sempra Energy (NYSE: SRE).

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.